|
|
||||||||
Journal of Lipid Research, Vol 36, 1385-1391, Copyright © 1995 by Lipid Research, Inc.
H Mandel, M Getsis, M Rosenblat, M Berant and M Aviram
Mammalian cells acquire cellular cholesterol by de novo synthesis as well
as by uptake of low density lipoprotein (LDL). Peroxisomes contain enzymes
involved in the synthesis of cholesterol, and peroxisome- deficient (PD)
patients have been shown to have hypocholesterolemia and abnormal LDL. We
therefore decided to study whether cholesterol synthesis and cellular
uptake of LDL are impaired in cultured PD fibroblasts. The present study
demonstrates a significantly lower cellular cholesterol mass in fibroblasts
from three PD patients, as compared to control cells (41-59% of controls).
The rate of cholesterol synthesis was also reduced in all three PD cell
lines, being 16-20% of the control values. LDL binding and degradation by
fibroblasts were 3- to 5-fold higher in the PD cells as compared to control
cells. Similarly, enrichment of normal fibroblasts with tetracosanoic acid
(C- 24:0), a situation that could mimic the in vivo accumulation of very
long chain fatty acid (VLCFA) in PD cells, caused LDL binding and
degradation to be 4-fold higher than in non-treated cells. On the other
hand, the uptake of LDL derived from PD patients by normal fibroblasts was
markedly reduced (by up to 67%) in comparison to the cellular uptake of
normal LDL. Similar results were obtained in PD cells. This study
demonstrates a lower cellular cholesterol content and reduced cholesterol
synthesis rate in PD cell lines. In addition, we demonstrate that
regulation of the uptake of normal LDL by cellular LDL receptors is
operative in PD cells, whereas LDL derived from PD patients is not
recognized normally by the LDL receptor.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Reduced cellular cholesterol content in peroxisome-deficient fibroblasts is associated with impaired uptake of the patient's low density lipoprotein and with reduced cholesterol synthesis
Department of Pediatrics, Rambam Medical Center, Technion-Faculty of Medicine, Haifa, Israel.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. L. Hargrove, P. Greenspan, and D. K. Hartle Nutritional Significance and Metabolism of Very Long Chain Fatty Alcohols and Acids from Dietary Waxes Experimental Biology and Medicine, March 1, 2004; 229(3): 215 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Kovacs, J. E. Shackelford, K. N. Tape, M. J. Richards, P. L. Faust, S. J. Fliesler, and S. K. Krisans Disturbed Cholesterol Homeostasis in a Peroxisome-Deficient PEX2 Knockout Mouse Model Mol. Cell. Biol., January 1, 2004; 24(1): 1 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hogenboom, G. J. Romeijn, S. M. Houten, M. Baes, R. J. A. Wanders, and H. R. Waterham Absence of functional peroxisomes does not lead to deficiency of enzymes involved in cholesterol biosynthesis J. Lipid Res., January 1, 2002; 43(1): 90 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Aboushadi, W. H. Engfelt, V. G. Paton, and S. K. Krisans Role of Peroxisomes in Isoprenoid Biosynthesis J. Histochem. Cytochem., September 1, 1999; 47(9): 1127 - 1132. [Abstract] [Full Text] |
||||
![]() |
N. Aboushadi and S. K. Krisans Analysis of isoprenoid biosynthesis in peroxisomal-deficient Pex2 CHO cell lines J. Lipid Res., September 1, 1998; 39(9): 1781 - 1791. [Abstract] [Full Text] |
||||
![]() |
C. L. Baum, E. J. Reschly, A. K. Gayen, M. E. Groh, and K. Schadick Sterol Carrier Protein-2 Overexpression Enhances Sterol Cycling and Inhibits Cholesterol Ester Synthesis and High Density Lipoprotein Cholesterol Secretion J. Biol. Chem., March 7, 1997; 272(10): 6490 - 6498. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |